

Accelerate Drug Discovery with AI-Powered Knowledge & Target Exploration
LSKB is a cloud-based target exploration system specifically designed to support drug discovery. It integrates AI-driven literature interpretation with curated databases to power:
-
Target & biomarker discovery from disease data
-
Target prediction from compound structures
-
Drug repurposing and mechanism-of-action (MoA) inference
-
Toxicity & safety profiling
The platform combines diverse biomedical data sources—including compounds, genes, proteins, diseases, and functions—with AI-enhanced workflows for actionable insights .

Core Functional Modules
Target Exploration
-
Identify potential therapeutic targets based on disease profiles
Biomarker Discovery
-
Extract biomarker candidates through ontology-based inference
GO‑MoA Analysis
-
Link disease-target pairs to compound functions for repurposing and MoA hypothesis generation
Target Prediction
-
Predict targets from molecular structure similarity and assay data
Protein Similarity Extension
-
Expand candidate targets via structural and sequence-level similarity
Toxicity & Safety Insights
-
Surface liver- or mechanism-based toxicity targets with evidence
Expression‑Based MoA Parsing
-
Analyze MoA and toxicity from gene expression data (e.g., GSEA, zebrafish datasets)
Workflow Builder
-
Automate custom exploration pipelines and recursive updates
Decision Support Tool (ElpisMap)
-
Visualize compound–target networks using combined internal and external data
These modules support both intuitive hypothesis exploration and scalable target identification workflows .
Platform Benefits
-
Combines AI-based text mining (e.g., BERT or MNLI inference) with 12+ biomedical databases for high-quality semantic relationships
-
Capable of extracting protein–disease–compound relationships via multiple inference routes (target, repurposing, biomarker)
-
Supports safe exploration by integrating assay data and toxicity indicators
-
Enables customizable, repeatable pipelines for streamlined in-house or contracted analysis
Includes workflow visualization tools like ElpisMap to support decision-making based on compound activity patterns and network context

Microbiome Functional Knowledge Platform
@KIN Web DB (part of our @KIN series) is a curated web-accessible database that enriches microbiome CRO analyses with functional and mechanistic context.
KIN-db allows researchers to explore functional relationships between microbes by using a rich set of predefined hypotheses, categorized by biological functions, interaction types, and environmental contexts.
Types of Functional Insights:

Organization
Bacteria associated with specific body sites (oral cavity, skin, gut), or coexisting and interacting with dominant species in those sites.
Mechanisms
Bacteria with known functions across environments, including signal molecule production, bacterial interference, biofilm formation, skin barrier function, gut-brain axis, and disease association.
Health & Disease
Bacteria linked to health states, disease onset, treatment effects, antibiotics, and probiotic interactions.
Application
Bacteria relevant to product development or therapeutic outcomes, such as those involved in effectiveness, interaction, and impact in prebiotics, probiotics, or synbiotics.
Bacterial Interaction
Bacteria involved in interactions such as metabolic byproduct exchange, competition for nutrients or adhesion, biofilm formation/inhibition, host immune modulation, and compound signaling.
Enzyme Activity
Bacteria associated enzymes, including hydrolases, lyases, oxidases, reductases, and transferases, with relevance to enzymatic production and activity.
Metabolites
Bacteria metabolites, including synthesis, transformation, interaction with metabolic profiles, or antibiotic compound generation.
Toxicity
Bacteria associated toxins (e.g., endotoxins, exotoxins), and involved in toxicity mechanisms, pathogenicity, antibiotic resistance, quorum sensing, and disease symptoms.
Types of Functional Class and Aspect
Bacterial Interaction
-
Quorum Sensing
-
Biofilm Formation
-
Cross-Feeding
-
Competition for Nutrients
-
Antibiosis (e.g., bacteriocins)
-
Co-aggregation
-
Symbiosis
-
Antibiofilm Effect
-
Cooperation
-
Host Interaction
-
Virulence Factor Production
Host Interaction
-
Immune Modulation
-
Host Immune Response
-
Host Infection
-
Cell Death / Apoptosis
-
Inflammatory Response
-
Dysbiosis
-
Axis Dysfunction (Gut-Brain, Gut-Skin, etc.)
-
Behavioral Phenotype Changes
Metabolism & Enzymes
-
SCFA (Butyrate, Propionate, Acetate) Production
-
Vitamin Synthesis
-
Metabolic Shift
-
Enzymatic Activity:
-
Hydrolase, Oxidase, Kinase
-
Phosphatase, Protease, Lipase
-
Others
-
Toxicity & Resistance
-
Endotoxin
-
Exotoxin
-
Cytotoxin / Enterotoxin / Neurotoxin
-
Hemolysin
-
Antibiotic Resistance (efflux pumps, HGT, etc.)
-
Biofilm-Associated Resistance
-
Toxin Production Related to Pathogenicity
Environmental Influence
-
Nutrient Deprivation
-
Stress Conditions
-
Antibiotic Exposure
-
Circadian Rhythm Influence
-
Quorum Quenching
-
Signal Molecule Interference
Therapeutic Relevance
-
Drug Metabolism Modulation
-
Biomarker Association
-
Horizontal Gene Transfer
-
Antibiotic Efflux Pumps
-
Axis-Mediated Modulation
-
Microbial-Derived Therapeutics Potential